<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414&amp;utm_source=Chrome&amp;fc=20230708114047&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 14 Jan 2025 20:11:31 +0000</lastbuilddate>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39808105/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Jan 7:S0735-1097(24)10510-4. doi: 10.1016/j.jacc.2024.11.023. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39808105/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39808105</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.023>10.1016/j.jacc.2024.11.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39808105</guid>
<pubDate>Tue, 14 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Writing Group</dc:creator>
<dc:creator>Andrea M Russo</dc:creator>
<dc:creator>Milind Y Desai</dc:creator>
<dc:creator>Monika M Do</dc:creator>
<dc:creator>Javed Butler</dc:creator>
<dc:creator>Mina K Chung</dc:creator>
<dc:creator>Andrew E Epstein</dc:creator>
<dc:creator>Maya E Guglin</dc:creator>
<dc:creator>Wayne C Levy</dc:creator>
<dc:creator>Jonathan P Piccini</dc:creator>
<dc:creator>Rating Panel</dc:creator>
<dc:creator>Nicole M Bhave</dc:creator>
<dc:creator>Andrea M Russo</dc:creator>
<dc:creator>Milind Y Desai</dc:creator>
<dc:creator>Monika M Do</dc:creator>
<dc:creator>Amrut V Ambardekar</dc:creator>
<dc:creator>Nancy C Berg</dc:creator>
<dc:creator>Kenneth C Bilchick</dc:creator>
<dc:creator>G William Dec</dc:creator>
<dc:creator>Rakesh Gopinathannair</dc:creator>
<dc:creator>Janet K Han</dc:creator>
<dc:creator>Liviu Klein</dc:creator>
<dc:creator>Rachel J Lampert</dc:creator>
<dc:creator>Gurusher S Panjrath</dc:creator>
<dc:creator>Ryan R Reeves</dc:creator>
<dc:creator>Danita Marie Yoerger Sanborn</dc:creator>
<dc:creator>Lynne W Stevenson</dc:creator>
<dc:creator>Quynh A Truong</dc:creator>
<dc:creator>Paul D Varosy</dc:creator>
<dc:creator>Todd C Villines</dc:creator>
<dc:creator>Annabelle S Volgman</dc:creator>
<dc:creator>Karolina M Zareba</dc:creator>
<dc:date>2025-01-14</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing</dc:title>
<dc:identifier>pmid:39808105</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.023</dc:identifier>
</item>
<item>
<title>Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39805949/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>Atherosclerosis is a disease of large and medium arteries that can lead to life-threatening cardiovascular and cerebrovascular consequences, such as myocardial infarction and stroke. Moreover, atherosclerosis is a major contributor to cardiovascular-related mortality in individuals with diabetes mellitus. Diabetes aggravates the pathobiological mechanisms that underlie the development of atherosclerosis. Currently available anti-atherosclerotic drugs or strategies solely focus on optimal control...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 13. doi: 10.1038/s41569-024-01115-w. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Atherosclerosis is a disease of large and medium arteries that can lead to life-threatening cardiovascular and cerebrovascular consequences, such as myocardial infarction and stroke. Moreover, atherosclerosis is a major contributor to cardiovascular-related mortality in individuals with diabetes mellitus. Diabetes aggravates the pathobiological mechanisms that underlie the development of atherosclerosis. Currently available anti-atherosclerotic drugs or strategies solely focus on optimal control of systemic risk factors, including hyperglycaemia and dyslipidaemia, but do not adequately target the diabetes-exacerbated mechanisms of atherosclerotic cardiovascular disease, highlighting the need for targeted, mechanism-based therapies. This Review focuses on emerging pathological mechanisms and related novel therapeutic targets in atherosclerotic cardiovascular disease in patients with diabetes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39805949/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39805949</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01115-w>10.1038/s41569-024-01115-w</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39805949</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Abdul Waheed Khan</dc:creator>
<dc:creator>Karin A M Jandeleit-Dahm</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Atherosclerosis in diabetes mellitus: novel mechanisms and mechanism-based therapeutic approaches</dc:title>
<dc:identifier>pmid:39805949</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01115-w</dc:identifier>
</item>
<item>
<title>Cardiac optogenetics: controlling the heart with light</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39805948/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 13. doi: 10.1038/s41569-025-01119-0. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39805948/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39805948</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01119-0>10.1038/s41569-025-01119-0</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39805948</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Sasha B Forbes</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Cardiac optogenetics: controlling the heart with light</dc:title>
<dc:identifier>pmid:39805948</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01119-0</dc:identifier>
</item>
<item>
<title>Cardiac Plasticity in Hypertrophic Cardiomyopathy: Exercise as Medicine?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804911/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):145-148. doi: 10.1161/CIRCULATIONAHA.124.072649. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804911/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804911</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072649>10.1161/CIRCULATIONAHA.124.072649</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804911</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>James P MacNamara</dc:creator>
<dc:creator>Michael P Ayers</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Cardiac Plasticity in Hypertrophic Cardiomyopathy: Exercise as Medicine?</dc:title>
<dc:identifier>pmid:39804911</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072649</dc:identifier>
</item>
<item>
<title>Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804910/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):e22. doi: 10.1161/CIRCULATIONAHA.124.068936. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804910/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804910</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068936>10.1161/CIRCULATIONAHA.124.068936</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804910</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Jun-Zhang Chen</dc:creator>
<dc:creator>Yi Liang</dc:creator>
<dc:creator>Bo Liang</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Chen et al Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</dc:title>
<dc:identifier>pmid:39804910</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068936</dc:identifier>
</item>
<item>
<title>Recognized Outstanding Reviewers for &lt;em>;Circulation&lt;/em>; in 2024</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804909/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):125. doi: 10.1161/CIRCULATIONAHA.124.073245. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804909/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804909</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073245>10.1161/CIRCULATIONAHA.124.073245</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804909</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Darren K McGuire</dc:creator>
<dc:creator>James A de Lemos</dc:creator>
<dc:creator>Joseph A Hill</dc:creator>
<dc:creator>Circulation Editors Team</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Recognized Outstanding Reviewers for &lt;em>;Circulation&lt;/em>; in 2024</dc:title>
<dc:identifier>pmid:39804909</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073245</dc:identifier>
</item>
<item>
<title>Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Pilot Randomized Controlled Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804908/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):196-198. doi: 10.1161/CIRCULATIONAHA.124.071452. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804908/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804908</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071452>10.1161/CIRCULATIONAHA.124.071452</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804908</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Jinbo Hu</dc:creator>
<dc:creator>Qixin Zhou</dc:creator>
<dc:creator>Yue Sun</dc:creator>
<dc:creator>Zhengping Feng</dc:creator>
<dc:creator>Jun Yang</dc:creator>
<dc:creator>Wenwen He</dc:creator>
<dc:creator>Ying Song</dc:creator>
<dc:creator>Yue Wang</dc:creator>
<dc:creator>Xiangjun Chen</dc:creator>
<dc:creator>Hang Shen</dc:creator>
<dc:creator>Ying Jing</dc:creator>
<dc:creator>Shumin Yang</dc:creator>
<dc:creator>Qifu Li</dc:creator>
<dc:creator>CONPASS Group</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: A Pilot Randomized Controlled Trial</dc:title>
<dc:identifier>pmid:39804908</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071452</dc:identifier>
</item>
<item>
<title>Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804907/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):129-131. doi: 10.1161/CIRCULATIONAHA.124.068331. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804907/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804907</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068331>10.1161/CIRCULATIONAHA.124.068331</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804907</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Abdul Wahed Sidiqi</dc:creator>
<dc:creator>Diana Dad Zada</dc:creator>
<dc:creator>Nader Ahmad Exeer</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Global Rounds Afghanistan: A Critical Overview of Cardiovascular Medicine</dc:title>
<dc:identifier>pmid:39804907</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068331</dc:identifier>
</item>
<item>
<title>Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804906/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):e23. doi: 10.1161/CIRCULATIONAHA.124.071536. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804906/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804906</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071536>10.1161/CIRCULATIONAHA.124.071536</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804906</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Meiyan Sun</dc:creator>
<dc:creator>Shufang He</dc:creator>
<dc:creator>Ji Hu</dc:creator>
<dc:creator>Ye Zhang</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Sun et al to Letter Regarding Article, "Piezo1-Mediated Neurogenic Inflammatory Cascade Exacerbates Ventricular Remodeling After Myocardial Infarction"</dc:title>
<dc:identifier>pmid:39804906</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071536</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804905/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):188-192. doi: 10.1161/CIRCULATIONAHA.124.073304. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804905/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804905</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.073304>10.1161/CIRCULATIONAHA.124.073304</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804905</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:39804905</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.073304</dc:identifier>
</item>
<item>
<title>Swinging Pendulum Between Risks and Benefits of Antiplatelet Agents: A Call for Consistency in the Interpretation of Evidence and Guideline Recommendations</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804904/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):126-128. doi: 10.1161/CIRCULATIONAHA.124.070797. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804904/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804904</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070797>10.1161/CIRCULATIONAHA.124.070797</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804904</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Antonio Landi</dc:creator>
<dc:creator>Diana A Gorog</dc:creator>
<dc:creator>Marco Valgimigli</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Swinging Pendulum Between Risks and Benefits of Antiplatelet Agents: A Call for Consistency in the Interpretation of Evidence and Guideline Recommendations</dc:title>
<dc:identifier>pmid:39804904</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070797</dc:identifier>
</item>
<item>
<title>Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804903/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Jan 14;151(2):193-195. doi: 10.1161/CIRCULATIONAHA.124.070509. Epub 2025 Jan 13.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804903/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804903</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070509>10.1161/CIRCULATIONAHA.124.070509</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804903</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Tormod Rogne</dc:creator>
<dc:creator>Dipender Gill</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Adverse Pregnancy Outcomes and Coronary Artery Disease Risk: A Negative Control Mendelian Randomization Study</dc:title>
<dc:identifier>pmid:39804903</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070509</dc:identifier>
</item>
<item>
<title>Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804243/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: An AI model applied to a single ECG image defined the risk of future HF, representing a digital biomarker for stratifying HF risk.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 13:ehae914. doi: 10.1093/eurheartj/ehae914. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Current heart failure (HF) risk stratification strategies require comprehensive clinical evaluation. In this study, artificial intelligence (AI) applied to electrocardiogram (ECG) images was examined as a strategy to predict HF risk.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Across multinational cohorts in the Yale New Haven Health System (YNHHS), UK Biobank (UKB), and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), individuals without baseline HF were followed for the first HF hospitalization. An AI-ECG model that defines cross-sectional left ventricular systolic dysfunction from 12-lead ECG images was used, and its association with incident HF was evaluated. Discrimination was assessed using Harrell's C-statistic. Pooled cohort equations to prevent HF (PCP-HF) were used as a comparator.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Among 231 285 YNHHS patients, 4472 had primary HF hospitalizations over 4.5 years (inter-quartile range 2.5-6.6). In UKB and ELSA-Brasil, among 42 141 and 13 454 people, 46 and 31 developed HF over 3.1 (2.1-4.5) and 4.2 (3.7-4.5) years. A positive AI-ECG screen portended a 4- to 24-fold higher risk of new-onset HF [age-, sex-adjusted hazard ratio: YNHHS, 3.88 (95% confidence interval 3.63-4.14); UKB, 12.85 (6.87-24.02); ELSA-Brasil, 23.50 (11.09-49.81)]. The association was consistent after accounting for comorbidities and the competing risk of death. Higher probabilities were associated with progressively higher HF risk. Model discrimination was 0.718 in YNHHS, 0.769 in UKB, and 0.810 in ELSA-Brasil. In YNHHS and ELSA-Brasil, incorporating AI-ECG with PCP-HF yielded a significant improvement in discrimination over PCP-HF alone.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: An AI model applied to a single ECG image defined the risk of future HF, representing a digital biomarker for stratifying HF risk.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804243/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804243</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae914>10.1093/eurheartj/ehae914</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804243</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Lovedeep S Dhingra</dc:creator>
<dc:creator>Arya Aminorroaya</dc:creator>
<dc:creator>Veer Sangha</dc:creator>
<dc:creator>Aline F Pedroso</dc:creator>
<dc:creator>Folkert W Asselbergs</dc:creator>
<dc:creator>Luisa C C Brant</dc:creator>
<dc:creator>Sandhi M Barreto</dc:creator>
<dc:creator>Antonio Luiz P Ribeiro</dc:creator>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:creator>Evangelos K Oikonomou</dc:creator>
<dc:creator>Rohan Khera</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Heart failure risk stratification using artificial intelligence applied to electrocardiogram images: a multinational study</dc:title>
<dc:identifier>pmid:39804243</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae914</dc:identifier>
</item>
<item>
<title>Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804231/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The externally validated machine learning-based model, exclusively utilizing features from the 12-lead electrocardiogram, outperformed the HEART score in stratifying the mortality risk of patients with acute chest pain. This may have the potential to impact the precision of care delivery and the allocation of resources to those at highest risk of adverse events.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 13:ehae880. doi: 10.1093/eurheartj/ehae880. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: The importance of risk stratification in patients with chest pain extends beyond diagnosis and immediate treatment. This study sought to evaluate the prognostic value of electrocardiogram feature-based machine learning models to risk-stratify all-cause mortality in those with chest pain.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This was a prospective observational cohort study of consecutive, non-traumatic patients with chest pain. All-cause death was ascertained from multiple sources, including the CDC National Death Index registry. Six machine learning models were trained for survival analysis using 73 morphological electrocardiogram features (80% training with 10-fold cross-validation and 20% testing), followed by a variational Bayesian Gaussian mixture model to define distinct risk groups. The resulting classification performance was compared against the HEART score.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The derivation cohort included 4015 patients (age 59 ± 16 years, 47% women). The mortality rate was 20.3% after a median follow-up period of 3.05 years (interquartile range 1.75-5.32). Extra Survival Trees outperformed other forecasting models, and the derived risk groups successfully classified patients into low-, moderate-, and high-risk groups (log-rank test statistic = 121.14, P &lt; .001). This model outperformed the HEART score, reducing the rate of missed events by >;90% with a negative predictive value and sensitivity of 93.4% and 85.9%, compared to 89.0% and 75.0%, respectively. In an independent external testing cohort (N = 3095, age 59 ± 15 years, 44% women, 30-day mortality 3.5%), patients in the moderate [odds ratio 3.62 (1.35-9.74)] and high [odds ratio 6.12 (2.38-15.75)] risk groups had significantly higher odds of mortality compared to those in the low-risk group.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The externally validated machine learning-based model, exclusively utilizing features from the 12-lead electrocardiogram, outperformed the HEART score in stratifying the mortality risk of patients with acute chest pain. This may have the potential to impact the precision of care delivery and the allocation of resources to those at highest risk of adverse events.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804231/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804231</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae880>10.1093/eurheartj/ehae880</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804231</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Zeineb Bouzid</dc:creator>
<dc:creator>Ervin Sejdic</dc:creator>
<dc:creator>Christian Martin-Gill</dc:creator>
<dc:creator>Ziad Faramand</dc:creator>
<dc:creator>Stephanie Frisch</dc:creator>
<dc:creator>Mohammad Alrawashdeh</dc:creator>
<dc:creator>Stephanie Helman</dc:creator>
<dc:creator>Tanmay A Gokhale</dc:creator>
<dc:creator>Nathan T Riek</dc:creator>
<dc:creator>Karina Kraevsky-Phillips</dc:creator>
<dc:creator>Richard E Gregg</dc:creator>
<dc:creator>Susan M Sereika</dc:creator>
<dc:creator>Gilles Clermont</dc:creator>
<dc:creator>Murat Akcakaya</dc:creator>
<dc:creator>Jessica K Zègre-Hemsey</dc:creator>
<dc:creator>Samir Saba</dc:creator>
<dc:creator>Clifton W Callaway</dc:creator>
<dc:creator>Salah S Al-Zaiti</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Electrocardiogram-based machine learning for risk stratification of patients with suspected acute coronary syndrome</dc:title>
<dc:identifier>pmid:39804231</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae880</dc:identifier>
</item>
<item>
<title>Artificial intelligence and mortality prediction in acute coronary syndromes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39804226/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 13:ehae475. doi: 10.1093/eurheartj/ehae475. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39804226/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39804226</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae475>10.1093/eurheartj/ehae475</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39804226</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Zachi I Attia</dc:creator>
<dc:creator>Paul A Friedman</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Artificial intelligence and mortality prediction in acute coronary syndromes</dc:title>
<dc:identifier>pmid:39804226</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae475</dc:identifier>
</item>
<item>
<title>Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39801189/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Overweight and obesity are common in patients with HeFH and contribute to ASCVD risk from childhood, independent of LDL-C and lipid-lowering medication. Sustained body weight management is needed to reduce the risk of ASCVD in HeFH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 13:ehae791. doi: 10.1093/eurheartj/ehae791. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Overweight and obesity are modifiable risk factors for atherosclerotic cardiovascular disease (ASCVD) in the general population, but their prevalence in individuals with heterozygous familial hypercholesterolaemia (HeFH) and whether they confer additional risk of ASCVD independent of LDL cholesterol (LDL-C) remains unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Cross-sectional analysis was conducted in 35 540 patients with HeFH across 50 countries, in the EAS FH Studies Collaboration registry. Prevalence of World Health Organization-defined body mass index categories was investigated in adults (n = 29 265) and children/adolescents (n = 6275); and their association with prevalent ASCVD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Globally, 52% of adults and 27% of children with HeFH were overweight or obese, with the highest prevalence noted in Northern Africa/Western Asia. A higher overweight/obesity prevalence was found in non-high-income vs. high-income countries. Median age at familial hypercholesterolaemia diagnosis in adults with obesity was 9 years older than in normal weight adults. Obesity was associated with a more atherogenic lipid profile independent of lipid-lowering medication. Prevalence of coronary artery disease increased progressively across body mass index categories in both children and adults. Compared with normal weight, obesity was associated with higher odds of coronary artery disease in children (odds ratio 9.28, 95% confidence interval 1.77-48.77, adjusted for age, sex, lipids, and lipid-lowering medication) and coronary artery disease and stroke in adults (odds ratio 2.35, 95% confidence interval 2.10-2.63 and odds ratio 1.65, 95% confidence interval 1.27-2.14, respectively), but less consistently with peripheral artery disease. Adjusting for diabetes, hypertension and smoking modestly attenuated the associations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Overweight and obesity are common in patients with HeFH and contribute to ASCVD risk from childhood, independent of LDL-C and lipid-lowering medication. Sustained body weight management is needed to reduce the risk of ASCVD in HeFH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39801189/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39801189</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae791>10.1093/eurheartj/ehae791</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39801189</guid>
<pubDate>Mon, 13 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Amany Elshorbagy</dc:creator>
<dc:creator>Antonio J Vallejo-Vaz</dc:creator>
<dc:creator>Fotios Barkas</dc:creator>
<dc:creator>Alexander R M Lyons</dc:creator>
<dc:creator>Christophe A T Stevens</dc:creator>
<dc:creator>Kanika I Dharmayat</dc:creator>
<dc:creator>Alberico L Catapano</dc:creator>
<dc:creator>Tomas Freiberger</dc:creator>
<dc:creator>G Kees Hovingh</dc:creator>
<dc:creator>Pedro Mata</dc:creator>
<dc:creator>Frederick J Raal</dc:creator>
<dc:creator>Raul D Santos</dc:creator>
<dc:creator>Handrean Soran</dc:creator>
<dc:creator>Gerald F Watts</dc:creator>
<dc:creator>Marianne Abifadel</dc:creator>
<dc:creator>Carlos A Aguilar-Salinas</dc:creator>
<dc:creator>Khalid F Alhabib</dc:creator>
<dc:creator>Mutaz Alkhnifsawi</dc:creator>
<dc:creator>Wael Almahmeed</dc:creator>
<dc:creator>Fahad Alnouri</dc:creator>
<dc:creator>Rodrigo Alonso</dc:creator>
<dc:creator>Khalid Al-Rasadi</dc:creator>
<dc:creator>Ahmad Al-Sarraf</dc:creator>
<dc:creator>Marcello Arca</dc:creator>
<dc:creator>Tester F Ashavaid</dc:creator>
<dc:creator>Maurizio Averna</dc:creator>
<dc:creator>Maciej Banach</dc:creator>
<dc:creator>Marianne Becker</dc:creator>
<dc:creator>Christoph J Binder</dc:creator>
<dc:creator>Mafalda Bourbon</dc:creator>
<dc:creator>Liam R Brunham</dc:creator>
<dc:creator>Krzysztof Chlebus</dc:creator>
<dc:creator>Pablo Corral</dc:creator>
<dc:creator>Diogo Cruz</dc:creator>
<dc:creator>Kairat Davletov</dc:creator>
<dc:creator>Olivier S Descamps</dc:creator>
<dc:creator>Bambang Dwiputra</dc:creator>
<dc:creator>Marat Ezhov</dc:creator>
<dc:creator>Urh Groselj</dc:creator>
<dc:creator>Mariko Harada-Shiba</dc:creator>
<dc:creator>Kirsten B Holven</dc:creator>
<dc:creator>Steve E Humphries</dc:creator>
<dc:creator>Meral Kayikcioglu</dc:creator>
<dc:creator>Weerapan Khovidhunkit</dc:creator>
<dc:creator>Katarina Lalic</dc:creator>
<dc:creator>Gustavs Latkovskis</dc:creator>
<dc:creator>Ulrich Laufs</dc:creator>
<dc:creator>Evangelos Liberopoulos</dc:creator>
<dc:creator>Marcos M Lima-Martinez</dc:creator>
<dc:creator>Vincent Maher</dc:creator>
<dc:creator>A David Marais</dc:creator>
<dc:creator>Winfried März</dc:creator>
<dc:creator>Erkin Mirrakhimov</dc:creator>
<dc:creator>André R Miserez</dc:creator>
<dc:creator>Olena Mitchenko</dc:creator>
<dc:creator>Hapizah Nawawi</dc:creator>
<dc:creator>Børge G Nordestgaard</dc:creator>
<dc:creator>Andrie G Panayiotou</dc:creator>
<dc:creator>György Paragh</dc:creator>
<dc:creator>Zaneta Petrulioniene</dc:creator>
<dc:creator>Belma Pojskic</dc:creator>
<dc:creator>Arman Postadzhiyan</dc:creator>
<dc:creator>Ashraf Reda</dc:creator>
<dc:creator>Željko Reiner</dc:creator>
<dc:creator>Ximena Reyes</dc:creator>
<dc:creator>Fouzia Sadiq</dc:creator>
<dc:creator>Wilson Ehidiamen Sadoh</dc:creator>
<dc:creator>Heribert Schunkert</dc:creator>
<dc:creator>Aleksandr B Shek</dc:creator>
<dc:creator>Erik Stroes</dc:creator>
<dc:creator>Ta-Chen Su</dc:creator>
<dc:creator>Tavintharan Subramaniam</dc:creator>
<dc:creator>Andrey V Susekov</dc:creator>
<dc:creator>Myra Tilney</dc:creator>
<dc:creator>Brian Tomlinson</dc:creator>
<dc:creator>Thanh Huong Truong</dc:creator>
<dc:creator>Alexandros D Tselepis</dc:creator>
<dc:creator>Anne Tybjærg-Hansen</dc:creator>
<dc:creator>Alejandra Vázquez-Cárdenas</dc:creator>
<dc:creator>Margus Viigimaa</dc:creator>
<dc:creator>Branislav Vohnout</dc:creator>
<dc:creator>Shizuya Yamashita</dc:creator>
<dc:creator>Kausik K Ray</dc:creator>
<dc:date>2025-01-13</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry</dc:title>
<dc:identifier>pmid:39801189</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae791</dc:identifier>
</item>
<item>
<title>ERC-funded grant: cardiac regeneration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39797422/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 11:ehae873. doi: 10.1093/eurheartj/ehae873. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39797422/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39797422</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae873>10.1093/eurheartj/ehae873</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39797422</guid>
<pubDate>Sat, 11 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Cristina Villa Del Campo</dc:creator>
<dc:creator>Inés Rivero-García</dc:creator>
<dc:creator>Miguel Torres</dc:creator>
<dc:date>2025-01-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>ERC-funded grant: cardiac regeneration</dc:title>
<dc:identifier>pmid:39797422</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae873</dc:identifier>
</item>
<item>
<title>Personalized management of tricuspid valve regurgitation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39797420/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Jan 11:ehae733. doi: 10.1093/eurheartj/ehae733. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39797420/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39797420</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae733>10.1093/eurheartj/ehae733</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39797420</guid>
<pubDate>Sat, 11 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Philipp Lurz</dc:creator>
<dc:creator>Edoardo Zancanaro</dc:creator>
<dc:creator>Karl-Patrik Kresoja</dc:creator>
<dc:date>2025-01-11</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Personalized management of tricuspid valve regurgitation</dc:title>
<dc:identifier>pmid:39797420</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae733</dc:identifier>
</item>
<item>
<title>The rapid delayed-rectifier potassium current: a biophysical basis for cardiac repolarization and arrhythmia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39794610/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Jan 10. doi: 10.1038/s41569-025-01116-3. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39794610/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39794610</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01116-3>10.1038/s41569-025-01116-3</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39794610</guid>
<pubDate>Fri, 10 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Joseph E Carr</dc:creator>
<dc:date>2025-01-10</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>The rapid delayed-rectifier potassium current: a biophysical basis for cardiac repolarization and arrhythmia</dc:title>
<dc:identifier>pmid:39794610</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01116-3</dc:identifier>
</item>
<item>
<title>Direct visualization of electric-field-stimulated ion conduction in a potassium channel</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39793560/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>Understanding protein function would be facilitated by direct, real-time observation of chemical kinetics in the atomic structure. The selectivity filter (SF) of the K^(+) channel provides an ideal model, catalyzing the dehydration and transport of K^(+) ions across the cell membrane through a narrow pore. We used a "pump-probe" method called electric-field-stimulated time-resolved X-ray crystallography (EFX) to initiate and observe K^(+) conduction in the NaK2K channel in both directions on the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Jan 9;188(1):77-88.e15. doi: 10.1016/j.cell.2024.12.006.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Understanding protein function would be facilitated by direct, real-time observation of chemical kinetics in the atomic structure. The selectivity filter (SF) of the K<sup>+</sup> channel provides an ideal model, catalyzing the dehydration and transport of K<sup>+</sup> ions across the cell membrane through a narrow pore. We used a "pump-probe" method called electric-field-stimulated time-resolved X-ray crystallography (EFX) to initiate and observe K<sup>+</sup> conduction in the NaK2K channel in both directions on the timescale of the transport process. We observe both known and potentially new features in the high-energy conformations visited along the conduction pathway, including the associated dynamics of protein residues that control selectivity and conduction rate. A single time series of one channel in action shows the orderly appearance of features observed in diverse homologs with diverse methods, arguing for deep conservation of the dynamics underlying the reaction coordinate in this protein family.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39793560/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39793560</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.12.006>10.1016/j.cell.2024.12.006</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39793560</guid>
<pubDate>Fri, 10 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>BoRam Lee</dc:creator>
<dc:creator>K Ian White</dc:creator>
<dc:creator>Michael Socolich</dc:creator>
<dc:creator>Margaret A Klureza</dc:creator>
<dc:creator>Robert Henning</dc:creator>
<dc:creator>Vukica Srajer</dc:creator>
<dc:creator>Rama Ranganathan</dc:creator>
<dc:creator>Doeke R Hekstra</dc:creator>
<dc:date>2025-01-10</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Direct visualization of electric-field-stimulated ion conduction in a potassium channel</dc:title>
<dc:identifier>pmid:39793560</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.12.006</dc:identifier>
</item>
<item>
<title>Selective excitation of bacteria enables growth suppression without antibiotics</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39793559/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250114151130&amp;v=2.18.0.post9+e462414
      <description>In a recently published article in Device, Saehyun Kim et al. report that selective excitation of bacteria can inhibit their proliferation in an antibiotic-free manner. We herein discuss the molecular and thermodynamic principles underlying this "selective excitability," which provides a new aspect to understand bacterial physiology.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Jan 9;188(1):1-3. doi: 10.1016/j.cell.2024.11.035.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In a recently published article in Device, Saehyun Kim et al. report that selective excitation of bacteria can inhibit their proliferation in an antibiotic-free manner. We herein discuss the molecular and thermodynamic principles underlying this "selective excitability," which provides a new aspect to understand bacterial physiology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39793559/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250114151130&v=2.18.0.post9+e462414">39793559</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.11.035>10.1016/j.cell.2024.11.035</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39793559</guid>
<pubDate>Fri, 10 Jan 2025 06:00:00 -0500</pubDate>
<dc:creator>Michael W Chen</dc:creator>
<dc:creator>Yifan Dai</dc:creator>
<dc:date>2025-01-10</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Selective excitation of bacteria enables growth suppression without antibiotics</dc:title>
<dc:identifier>pmid:39793559</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.11.035</dc:identifier>
</item>





























</channel>
</rss>